Search research articles
Contact Us
Filters
Showing results (1091-1100 of 1,171) with videos related to
Page
of 118
Sort By:
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery
|
May 2, 2015
Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study
Lindsey M Hoffman, Maryam Fouladi, James Olson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2009
Tyrosine kinase inhibitor enhances the bioavailability of oral irinotecan in pediatric patients with refractory solid tumors
Wayne L Furman, Fariba Navid, Najat C Daw, et al.
Breast (Edinburgh, Scotland)
|
June 10, 2023
Development of the HT&Me intervention to support women with breast cancer to adhere to adjuvant endocrine therapy and improve quality of life
Sarah-Jane F Stewart, Joanna Slodkowska-Barabasz, Lucy McGeagh, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery
|
July 20, 2015
A phase I trial and PK study of cediranib (AZD2171), an orally bioavailable pan-VEGFR inhibitor, in children with recurrent or refractory primary CNS tumors
Mark W Kieran, Susan Chi, Stewart Goldman, et al.
Biorxiv : the Preprint Server for Biology
|
January 23, 2026
Harmine Selectively Drives Human Beta Cell Differentiation and Function Via Protein Kinase A Pathways
Peng Wang, Kunal Kumar, Luca Lambertini, et al.
Journal of Neuro-Oncology
|
April 11, 2015
An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN)
Mariko DeWire, Maryam Fouladi, David C Turner, et al.
EGEMS (Washington, DC)
|
May 4, 2016
Consensus Statement on Electronic Health Predictive Analytics: A Guiding Framework to Address Challenges
Ruben Amarasingham, Anne-Marie J Audet, David W Bates, et al.
Cancer
|
September 2, 2011
A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma
Leo A Niemeier, Haruko Kuffner Akatsu, Chi Song, et al.
The Journal of Clinical Investigation
|
June 14, 2022
Disrupting the DREAM complex enables proliferation of adult human pancreatic β cells
Peng Wang, Esra Karakose, Carmen Argmann, et al.
Cell Metabolism
|
December 25, 2018
Combined Inhibition of DYRK1A, SMAD, and Trithorax Pathways Synergizes to Induce Robust Replication in Adult Human Beta Cells
Peng Wang, Esra Karakose, Hongtao Liu, et al.
Page
of 118
Search research articles
Search
Showing results (1091-1100 of 1,171) with videos related to
Sort By:
Page
of 118
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery
|
May 2, 2015
Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study
Lindsey M Hoffman, Maryam Fouladi, James Olson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 19, 2009
Tyrosine kinase inhibitor enhances the bioavailability of oral irinotecan in pediatric patients with refractory solid tumors
Wayne L Furman, Fariba Navid, Najat C Daw, et al.
Breast (Edinburgh, Scotland)
|
June 10, 2023
Development of the HT&Me intervention to support women with breast cancer to adhere to adjuvant endocrine therapy and improve quality of life
Sarah-Jane F Stewart, Joanna Slodkowska-Barabasz, Lucy McGeagh, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery
|
July 20, 2015
A phase I trial and PK study of cediranib (AZD2171), an orally bioavailable pan-VEGFR inhibitor, in children with recurrent or refractory primary CNS tumors
Mark W Kieran, Susan Chi, Stewart Goldman, et al.
Biorxiv : the Preprint Server for Biology
|
January 23, 2026
Harmine Selectively Drives Human Beta Cell Differentiation and Function Via Protein Kinase A Pathways
Peng Wang, Kunal Kumar, Luca Lambertini, et al.
Journal of Neuro-Oncology
|
April 11, 2015
An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN)
Mariko DeWire, Maryam Fouladi, David C Turner, et al.
EGEMS (Washington, DC)
|
May 4, 2016
Consensus Statement on Electronic Health Predictive Analytics: A Guiding Framework to Address Challenges
Ruben Amarasingham, Anne-Marie J Audet, David W Bates, et al.
Cancer
|
September 2, 2011
A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma
Leo A Niemeier, Haruko Kuffner Akatsu, Chi Song, et al.
The Journal of Clinical Investigation
|
June 14, 2022
Disrupting the DREAM complex enables proliferation of adult human pancreatic β cells
Peng Wang, Esra Karakose, Carmen Argmann, et al.
Cell Metabolism
|
December 25, 2018
Combined Inhibition of DYRK1A, SMAD, and Trithorax Pathways Synergizes to Induce Robust Replication in Adult Human Beta Cells
Peng Wang, Esra Karakose, Hongtao Liu, et al.
Page
of 118